{"anticipatedPostingDate":"2026-12","denomUnitsSelected":"Participants","description":"Bioanalytical measurements will be conducted on an ultra-high-performance liquid chromatography (uHPLC) with tandem mass spectrometric detection to determine the concentration of lenalidomide in blood using an assay developed and validated by the National Institutes of Health (NIH) Clinical Pharmacology Program.","reportingStatus":"NOT_POSTED","timeFrame":"Cycle 1 Day 1(C1D1), C1D7, C6D1 (one cycle = 21 days)","title":"Pharmacokinetics of Lenalidomide in Blood","type":"SECONDARY"}